D'Adamio Anthony 4

What Happened

• Anthony D'Adamio, SVP & General Counsel of Bioventus (BVS), had 9,925 restricted stock units (RSUs convert to one share each) vest/convert on April 10, 2026. Those RSUs resulted in the acquisition of 9,925 shares.
• To cover tax withholding, 4,312 of those shares were surrendered at an effective price of $9.06 per share, generating a withholding value of $39,067. Net shares delivered to D'Adamio after withholding: 5,613.
• This was not an open-market purchase or discretionary sale but a routine RSU settlement with tax withholding.

Key Details

• Transaction date: April 10, 2026 (reported on Form 4 filed April 14, 2026 — timely within SEC 2-business-day rule).
• Actions and codes: M = exercise/conversion of derivative (RSU settlement) for 9,925 shares; F = tax withholding — 4,312 shares disposed at $9.06 for $39,067.
• Net shares received: 5,613 (9,925 acquired less 4,312 withheld).
• Footnotes: F1 — each RSU = contingent right to one Class A share; F2 — these RSUs vest in four equal annual installments starting April 10, 2023, subject to continued service.
• Shares owned after the transaction: the filing does not state total post-transaction holdings (only the net shares delivered from this vesting).

Context

• This is a routine RSU vesting and tax-withholding event (common form of “cashless” settlement); withholding sales to cover taxes do not necessarily indicate a view on the company’s stock price.
• No open-market purchase or discretionary sale was reported in this filing.